Procter & Gamble CoPG
Price$143.95Intrinsic value$146.752% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $87B+3.3% YoYTTM through 30 Jun 2026
Net Income $16B+0.5% YoYTTM through 30 Jun 2026
Free Cash Flow $15.1BTTM through 30 Jun 2026

Margins

Current
Gross Margin49.5%
EBITDA Margin26.3%
Operating Margin21.5%
Net Margin18.4%

Returns

30.3%ROE
12.9%ROA
21.8%ROIC

Balance Sheet Health

Debt / Equity0.68x
Current Ratio0.73x
Net Debt$24.7B
Cash & Equivalents$9.9B

Quality Metrics

Altman Z-Score5.45
Piotroski F-Score7 / 9
FCF Margin17.4%
Rule of 4019.4
Earnings-Beat Rate100.0%

Multi-Year Trend

Revenue
'20'21'22'23'24'25'26
FY2026: $87B
Diluted EPS$6.62TTM
'20'21'22'23'24'25'26
FY2026: $6.62

Dividend

$2.15Per share, FY20261.45%Yield-8.8%5-yr growth

Capital Allocation

R&D Spend$2.1B
Capex Intensity5.1%

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.